Beijing Tong Ren Tang Chinese Medicine Company Limited
Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK) Stock Competitors & Peer Comparison
See (3613.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 3613.HK | HK$7.74 | -0.26% | 6.5B | 16.47 | HK$0.47 | +4.52% |
| 0241.HK | HK$4.72 | -1.46% | 76.1B | 33.71 | HK$0.14 | N/A |
| 1345.HK | HK$2.21 | -3.91% | 2.6B | 22.10 | HK$0.10 | +5.43% |
| 1110.HK | HK$0.49 | +1.04% | 286M | 48.50 | HK$0.01 | +6.54% |
| 3390.HK | HK$0.27 | -3.64% | 236.9M | -6.62 | -HK$0.04 | N/A |
| 0348.HK | HK$0.09 | +0.00% | 70.9M | -9.20 | -HK$0.01 | N/A |
| 0574.HK | HK$0.04 | -2.50% | 57.5M | -0.78 | -HK$0.05 | N/A |
| 2211.HK | HK$0.57 | +11.76% | 50.6M | -1.73 | -HK$0.33 | N/A |
Stock Comparison
3613.HK vs 0241.HK Comparison April 2026
3613.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3613.HK stands at 6.5B. In comparison, 0241.HK has a market cap of 76.1B. Regarding current trading prices, 3613.HK is priced at HK$7.74, while 0241.HK trades at HK$4.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3613.HK currently has a P/E ratio of 16.47, whereas 0241.HK's P/E ratio is 33.71. In terms of profitability, 3613.HK's ROE is +0.13%, compared to 0241.HK's ROE of +0.14%. Regarding short-term risk, 3613.HK is less volatile compared to 0241.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 3613.HK.Check 0241.HK's competition here